Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.
about
Notch in the development of thyroid C-cells and the treatment of medullary thyroid cancer.Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride.Suberoyl bis-hydroxamic acid enhances cytotoxicity induced by proteasome inhibitors in breast cancer cells.Expression of the active Notch1 decreases MTC tumor growth in vivo.Thailandepsin A-loaded and octreotide-functionalized unimolecular micelles for targeted neuroendocrine cancer therapy.The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancerNotch-1 Confers Chemoresistance in Lung Adenocarcinoma to Taxanes through AP-1/microRNA-451 Mediated Regulation of MDR-1.Notch1 Signaling Regulates the Aggressiveness of Differentiated Thyroid Cancer and Inhibits SERPINE1 Expression.Folates Induce Colorectal Carcinoma HT29 Cell Line Proliferation Through Notch1 Signaling.Notch1 signaling is irresponsible to the anti-leukemic effect of HDACis in B-ALL Nalm-6 cells.Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer.Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1.Histone deacetylase inhibitor thailandepsin-A activates Notch signaling and suppresses neuroendocrine cancer cell growth in vivo.Down-regulation of Notch1 signaling inhibits tumor growth in human hepatocellular carcinoma
P2860
Q33680709-DB946415-FDB8-400E-B552-2233420EFC00Q33804934-24BEACB7-EBF4-4ACE-9A9D-843971973D41Q35128130-72EDD730-ACE0-4785-8C21-C82E77CE8019Q35169079-ECF63616-6679-44DF-A806-DA3A8F5B2C63Q35963760-233DDFF3-8770-4853-901C-DC9F39781E49Q36164034-DCA18DF7-87BB-460A-B518-D63B511F01AFQ37393976-A04DC6F3-3EC2-4BCE-9ECB-E2B6B8CEB96BQ38796455-852ADCBA-F212-4A17-807A-6821D3756D98Q38895857-8387A954-2D54-4A0E-BB32-F92AE35E5328Q39280883-F562F6E3-481E-46B9-B9DA-6F634D13A29FQ39616057-E85268B4-E771-4F9A-B226-E5142783C637Q41712392-8F6E0FE4-91F8-445A-8AAD-3D7B4B502D22Q42378482-D14D79A8-5C92-4E77-A891-A1B304319F03Q42652080-9F9B36A1-08F0-439A-9C1B-7D67E86E5222
P2860
Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Suberoyl bishydroxamic acid ac ...... f medullary thyroid carcinoma.
@en
Suberoyl bishydroxamic acid ac ...... f medullary thyroid carcinoma.
@nl
type
label
Suberoyl bishydroxamic acid ac ...... f medullary thyroid carcinoma.
@en
Suberoyl bishydroxamic acid ac ...... f medullary thyroid carcinoma.
@nl
prefLabel
Suberoyl bishydroxamic acid ac ...... f medullary thyroid carcinoma.
@en
Suberoyl bishydroxamic acid ac ...... f medullary thyroid carcinoma.
@nl
P2093
P2860
P1476
Suberoyl bishydroxamic acid ac ...... of medullary thyroid carcinoma
@en
P2093
Herbert Chen
Renata Jaskula-Sztul
P2860
P2888
P304
P356
10.1245/S10434-008-0006-Z
P577
2008-06-18T00:00:00Z
P5875
P6179
1008115861